To OTC Journal Members:

The NASDAQ is like a patient just waking up from surgery. It is groggy, and vital signs are being checked to determine if the patient is indeed on the road to recovery. The success of the operation might not be known for some time. The patient is showing signs of coming back to consciousness, but we're not sure if the operation was a success. Last week's injection of pain medication from the Federal Reserve in the form of 1/2 point drop in interest rates was met with 300 points of pain relief in one day. However, The pain returned over the next three trading sessions. We know the patient wants to get well, its just hard to tell if this last surgical removal of value was enough to do the trick. Time will tell.

In the meantime, long term investors need not worry and short term investors need to stay light on their feet. We are looking at a new Trading Alert for the weekend, but market conditions will dictate its release. If everything comes together it will be a high percentage money making opportunity- We have been right on this one twice in the past.
 

10 Week Free Subscription to the Wall Street Journal- Offer Expires Monday

This month's MVP award expires next Monday, January 15th. The award is a free, no strings attached 10 week subscription to the Wall Street Journal.  If you are a new member and not familiar with this feature, we use our marketing leverage of our nearly 500,000 members to obtain special offers each month on behalf of our members. Monthly you are awarded 150 Membership Value Points which you can redeem for our special free offer. Just a reminder to act before Monday to take advantage of this special offer.

Apologies to our valued members outside the Continental United States. If you live in Alaska, Hawaii, or anywhere else outside the United States you do not qualify for this MVP Award according to the rules set by the Wall Street Journal.

SwingWire.com also has a lucrative incentive model for experienced investors and traders who consistently outperform the market. Share market ideas with other like-minded investors, establish a proven track record, provide insightful commentary, attract followers and ultimately become one of the Internet's highest paid and most sought after CyberAnalysts! 

Click here to receive your FREE 30-Day Trial Membership with no further obligation. Sign Up Today! 
 

Click Here to view our compensation on every company we have ever covered, or visit the following web address:  http://www.otcjournal.com/disclaimer.html for our full profiles and http://www.otcjournal.com/trading-alerts/disclaimer.html for Trading Alerts.

All statements and expressions are the sole  opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities  mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

The editor, members of the editor's family, and/or entities with  which they are affiliated, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication.

The profiles, critiques, and other editorial content of the OTCjournal.com may contain forward-looking statements relating to the expected capabilities of the companies mentioned herein.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN  SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN  CONSENT OF THE EDITORS OF OTCjournal.com.

We encourage our readers to invest carefully and read the investor information available at the web sites of  the Securities and Exchange Commission ("SEC") at http://www.sec.govand/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at  http://www.sec.gov/consumer/cyberfr.htm. Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.